Compare AU
Compare IXJ vs. QHAL
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are IXJ and QHAL. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.
Community Stats
IXJ | QHAL | |
---|---|---|
Popularity | Low | Low |
Pearlers invested | 240 | 62 |
Median incremental investment | $1,000.00 | $865.83 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,703.28 | $5,068.63 |
Average age group | 26 - 35 | > 35 |
Key Summary
IXJ | QHAL | |
---|---|---|
Strategy | IXJ.AX was created on 2001-11-13 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or smallcapitalisation stocks | QHAL.AX was created on 2019-03-21 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. QHAL.AX seeks to provide investors with access to a diversified portfolio of quality international companies from developed markets (ex-Australia) hedged into Australian dollars with the aim of providing investment returns, before fees and other costs, which track the performance of the Index. |
Top 3 holdings | Eli Lilly and Company (8.25 %) UnitedHealth Group Incorporated (5.81 %) Johnson & Johnson (4.72 %) | MSCI Global 'Quality' (ex-AUS hedged) (100 %) |
Top 3 industries | Other (99.98 %) Communication Services (0.02 %) | |
Top 3 countries | United States (99.97 %) | United States (77.72 %) Switzerland (4.96 %) United Kingdom of Great Britain and Northern Ireland (4.17 %) |
Management fee | 0.46 % | 0.43 % |
Key Summary
IXJ | QHAL | |
---|---|---|
Issuer | iShares | VanEck |
Tracking index | S&P Global 1200 Healthcare Sector Index - AUD | MSCI World ex Australia Quality 100% Hedged to AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.46 % | 0.43 % |
Price | $141.31 | $49.20 |
Size | $1.380 billion | $1.531 billion |
10Y return | 129.40 % | N/A |
Annual distribution/βdividend yield (5Y) | 1.26 % | 1.82 % |
Market | ASX | ASX |
First listed date | 11/03/2009 | 25/03/2019 |
Purchase fee | $6.50 | $6.50 |
Community Stats
IXJ | QHAL | |
---|---|---|
Popularity | Low | Low |
Pearlers invested | 240 | 62 |
Median incremental investment | $1,000.00 | $865.83 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,703.28 | $5,068.63 |
Average age group | 26 - 35 | > 35 |
Pros and Cons
IXJ | QHAL | |
---|---|---|
Pros |
|
|
Cons |
|
|
IXJ | QHAL |
---|---|
Higher exposure to US market | Lower exposure to US market |
Higher management fee | Lower management fee |
Lower price growth | Higher price growth |
Lower distribution yield | Higher distribution yield |